Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 1,868.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 790,483
  • Market Cap: £1,233.49m
  • RiskGrade: 128

FTSE 250 movers: Synthomer bubbles up, BBA Aviation flies lower

By Duncan Ferris

Date: Tuesday 05 Mar 2019

LONDON (ShareCast) - (Sharecast News) - London's FTSE 250 was up 0.09% at 19,427.96 in afternoon trade on Tuesday, as shares of Synthomer pressed higher a day after its full-year results.
The chemicals company had reported a 9.4% improvement in its full-year revenue to £1.6bn, with underlying profit before tax rising 3.9% to a record £135.1m.

A note from Berenberg analysts said: "Synthomer trades near three-year low P/Es at 10x 2019 levels. The difficulty in the Synthomer Buy case over the past few years has been the historical valuation premium raising the question of whether M&A potential has been priced. The issue is now moot. Shares now trade at a more than 25% discount to five-year averages of 14.3x, and one would need to go back to the pre-2013 days of Yule Catto to see them trade much lower on a consistent basis."

Brick manufacturer Ibstock was higher as it sounded an upbeat note on the outlook and reported a 19% increase in full-year pre-tax profit, while animal genetics specialist Genus was boosted by an upgrade to 'buy' at Liberum.

"The global hog industry will need to lift production to meet Chinese import demand and this will be followed by a rebuilding and modernisation of the Chinese industry. On top of this, Genus is gaining share in porcine globally; bovine profitability is being transformed; and gene editing research is making good progress," said a note from the broker.

Meanwhile, John Laing Group also climbed after it announced decent growth in its net asset value in its audited results for the year ended 31 December on Tuesday, with the figure per share rising to 323p at year-end, from 281p a year earlier.

Life and pensions consolidation company Phoenix Group was on the up after it announced a "strong" set of results for the year ended 31 December on Tuesday, with cash generation rising to £664m from £653m year-on-year.

BBA Aviation headed the fallers despite its full-year revenues coming in slightly ahead of consensus expectations, while specialty chemicals firm Elementis dropped as it posted a jump in annual revenues on Tuesday, but conceded that market conditions remained challenging.

Ted Baker retreated as Stifel cut its stance on the stock to 'sell' from 'hold' a day after the retailer said chief executive Ray Kelvin had resigned following last year's "forced hugging" scandal.

Market Movers

FTSE 250 (MCX) 19,427.96 0.09%


FTSE 250 - Risers

Synthomer (SYNT) 381.60p 4.55%
Ibstock (IBST) 259.80p 3.34%
Genus (GNS) 2,254.00p 3.11%
John Laing Group (JLG) 388.80p 2.80%
CLS Holdings (CLI) 252.00p 2.65%
Phoenix Group Holdings (PHNX) 725.10p 2.63%
JPMorgan Indian Investment Trust (JII) 661.00p 2.48%
IMI (IMI) 982.00p 2.29%
Man Group (EMG) 140.80p 2.29%
Vivo Energy (VVO) 132.18p 2.27%

FTSE 250 - Fallers

BBA Aviation (BBA) 237.00p -6.69%
Amigo Holdings (AMGO) 215.50p -5.07%
William Hill (WMH) 171.90p -4.07%
Elementis (ELM) 170.10p -3.90%
Royal Mail (RMG) 269.55p -3.14%
Ted Baker (TED) 1,922.00p -3.03%
Indivior (INDV) 107.50p -2.98%
Syncona Limited NPV (SYNC) 285.50p -2.89%
Just Group (JUST) 105.20p -2.59%
Metro Bank (MTRO) 945.35p -2.14%

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 790,483
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
12:04 60 @ 1,868.00p
12:04 8 @ 1,868.00p
12:04 60 @ 1,868.00p
12:04 9 @ 1,868.00p
12:04 60 @ 1,868.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page